검색어 : 통합검색[Christie Julie]
총 340건 중 340건 출력
, 34/34 페이지
-
331
- Is Centralisation of Cancer Services Associated With Under‐Treatment of Patients With High‐Risk Prostate Cancer?-A National Population‐Based Study
- Han, Lu; Mayne, Emily; Dodkins, Joanna; Sullivan, Richard; Cook, Adrian; Parry, Matthew; Nossiter, Julie; Cowling, Thomas E.; Tree, Alison; Clarke, Noel; van der Meulen, Jan; Aggarwal, Ajay; Faculty of Public Health and Policy The London School of Hygiene and Tropical Medicine London UK; Clinical Effectiveness Unit Royal College of Surgeons of England London UK; Faculty of Public Health and Policy The London School of Hygiene and Tropical Medicine London UK; Institute of Cancer Policy-King's College London London UK; Clinical Effectiveness Unit Royal College of Surgeons of England London UK; Clinical Effectiveness Unit Royal College of Surgeons of England London UK; Clinical Effectiveness Unit Royal College of Surgeons of England London UK; Faculty of Public Health and Policy The London School of Hygiene and Tropical Medicine London UK; Department of Radiotherapy The Royal Marsden Hospital London UK; Department of Urology The Christie NHS Trust London UK; Faculty of Public Health and Policy The London School of Hygiene and Tropical Medicine London UK; Faculty of Public Health and Policy The London School of Hygiene and Tropical Medicine London UK; (Cancer medicine, v.13, 2024, pp.e70403)
-
332
- Extended follow-up results beyond 2.5 years from the pivotal NHL-1 EPCORE trial: Subcutaneous epcoritamab monotherapy in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL).
- Karimi, Yasmin; Thieblemont, Catherine; Ghesquieres, Hervé ; Cheah, Chan Y; Clausen, Michael Roost; Cunningham, David; Jurczak, Wojciech; Linton, Kim M.; Hutchings, Martin; Phillips, Tycel Jovelle; Farooq, Umar; Kim, Won Seog; Dinh, Minh H; Ghosh, Jagannath; Pallai, Rajash; Wielgos-Bonvallet, Monica; Eskelund, Christian; Lugtenburg, Pieternella; Vose, Julie; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Assistance Publique & Hô pitaux de Paris (APHP), Hô pital Saint-Louis, Hé mato-oncologie, Université de Paris, Paris, France; Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Benite, France; Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia; Vejle Hospital, Vejle, Denmark; The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom; Maria Skłodowska-Curie National Research Institute of Oncology, Krakó w, Poland; The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom; Rigshospitalet and University of Copenhagen, Copenhagen, Denmark; University of Michigan Comprehensive Cancer Center (Present affiliation: City of Hope), Ann Arbor, MI; University of Iowa, Iowa City, IA; Samsung Medical Center, Seoul, South Korea; AbbVie, North; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.42, 2024, pp.7039-7039)
-
333
- EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL.
- Vose, Julie; Vitolo, Umberto; Lugtenburg, Pieternella; Chamuleau, Martine E.D.; Linton, Kim M.; Thieblemont, Catherine; Sonnevi, Kristina; Jurczak, Wojciech; Olszewski, Adam J.; Awan, Farrukh Tauseef; Okada, Craig Y.; Feldman, Tatyana A; Hutchings, Martin; Favaro, Elena; Hoehn, Daniela; Li, Zhu; Conlon, Rebekah; Sancho, Juan-Manuel; Chavez, Julio C.; University of Nebraska Medical Center, Omaha, NE; Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy; On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands; On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands; Manchester Cancer Research Centre, The Christie NHS Foundation Trust, University of Manchester, Manchester, United Kingdom; Assistance Publique & Hô pitaux de Paris (APHP), Hô pital Saint-Louis, Hé mato-oncologie, Université de Paris, Paris, France; Karolinska Institutet, Stockholm, Sweden; Maria Skłodowska-Curie National Research Institute of Oncology, Krakó w, Poland; Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University, Providence, RI; The University of Texas Southwestern Medical Center, Dallas, TX; OHSU Kn; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.42, 2024, pp.7015-7015)
-
334
- IL-4 induces CD22 expression to restrain the effector program of virtual memory T cells
- Yang, Bin; Piedfort, Ophé lie; Sanchez-Sanchez, Guillem; Lavergne, Arnaud; Gong, Meijiao; Peng, Garrie; Madrigal, Ariel; Petrellis, Georgios; Katsandegwaza, Brunette; Rodriguez, Lucia Rodriguez; Balthazar, Alexis; Meyer, Sarah J.; Van Isterdael, Gert; Van Duyse, Julie; Andris, Fabienne; Bai, Qiang; Marichal, Thomas; Machiels, Bé né dicte; Nitschke, Lars; Najafabadi, Hamed S.; King, Irah L.; Vermijlen, David; Dewals, Benjamin G.; Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine - FARAH, University of Liè ge, Liè ge, Belgium.; Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine - FARAH, University of Liè ge, Liè ge, Belgium.; Department of Pharmacotherapy and Pharmaceutics, Université Libre de Bruxelles (ULB), Brussels, Belgium.; GIGA-Genomics Core Facility, University of Liè ge, Liè ge, Belgium.; Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine - FARAH, University of Liè ge, Liè ge, Belgium.; Department of Microbiology and Immunology, Meakins-Christie Laboratories, Research Institute of McGill University Health Centre, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada.; Department of Infectious and Parasitic Diseases, Faculty of Veterinary Medicine - FARAH, University of Liè ge, Liè ge, Belgium.; (Science immunology, v.10, 2025, pp.eadk4841)
-
335
- 3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma
- Vose, Julie M.; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Farooq, Umar; Feldman, Tatyana; Ghesquieres, Herve; Jurczak, Wojciech; Linton, Kim; Thieblemont, Catherine; Phillips, Tycel J.; Kim, Won Seog; Jafarinasabian, Pegah; D'Angelo Må nsson, Barbara; Soong, David; Steele, Andrew J.; Li, Zhu; Eskelund, Christian; Hutchings, Martin; Karimi, Yasmin H.; 1University of Nebraska Medical Center, Omaha, NE; 2Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia; 3Vejle Hospital, Vejle, Denmark; 4Royal Marsden NHS Foundation Trust, London, United Kingdom; 5University of Iowa, Iowa City, IA; 6John Theurer Cancer Center at Hackensack Meridian Health, HMH School of Medicine, Hackensack, NJ; 7Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bé nite, France; 8MSC National Research Institute of Oncology, Krakó w, Poland; 9The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom; 10Assistance Publique & Hô pitaux de Paris (APHP), Hô pital Saint-Louis, Hé mato-oncologie, Université de Paris, Paris, France; 11University of Michigan Comprehensive Cancer Center (present affiliation: City of Hope, Duarte, CA), Ann Arbor, MI; 12Samsung Medical Center, Seoul, Kor; (Blood, v.144, 2024, pp.4480-4480)
-
336
- Prospektive Kohortenstudie von InspECT zur Sicherheit und Wirksamkeit der Elektrochemotherapie bei Hauttumoren und Metastasen in Abhängigkeit von Ulzeration
- Claussen, Carla Sophie; Moir, Graeme; Bechara, Falk G.; Orlando, Antonio; Matteucci, Paolo; Mowatt, David; Clover, Anthony James P.; Mascherini, Matteo; Gehl, Julie; Muir, Tobian; Sersa, Gregor; Groselj, Ales; Odili, Joy; Giorgione, Roberto; Campana, Luca Giovanni; Bertino, Giulia; Curatolo, Pietro; Banerjee, Shramana; Kis, Erika; Quaglino, Pietro; Pritchard‐ Jones, Rowan; De Terlizzi, Francesca; Grischke, Eva‐ Maria; Kunte, Christian; Department of Dermatosurgery and Dermatology Artemed Clinic of Munich Munich Germany; The Royal London Hospital & QMUL Bart’s Health NHS Trust Department of Cutaneous Medicine & Surgery London United Kingdom; Department of Dermatologic Surgery St. Josef Hospital Ruhr‐ University Bochum Bochum Germany; Department of Plastic and Reconstructive Surgery Southmead Hospital North Bristol NHS Trust Bristol United Kingdom; Department of Plastic surgery Castle Hill Hospital Cottingham United Kingdom; Plastic Surgery Department The Christie Hospital NHS Foundation trust Manchester United Kingdom; Department of Plastic Surgery Cork University Hospital Cork Ireland; Clinica Chirurgica 1 - Ospedale Policlinico San Martino University of Genova Genova Italy; Center for Experimental Drug and Gene Electrotransfer (C*EDGE) Department of Clinical Oncology and Palliative Care Zealand University Hospital Roskilde Denmark; Plastic Surgery Department James Cook University Hospital Middlesbro; (Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, v.20, 2022, pp.470-482)
-
337
- Prospective cohort study by InspECT on safety and efficacy of electrochemotherapy for cutaneous tumors and metastases depending on ulceration
- Claussen, Carla Sophie; Moir, Graeme; Bechara, Falk G.; Orlando, Antonio; Matteucci, Paolo; Mowatt, David; Clover, Anthony James P.; Mascherini, Matteo; Gehl, Julie; Muir, Tobian; Sersa, Gregor; Groselj, Ales; Odili, Joy; Giorgione, Roberto; Campana, Luca Giovanni; Bertino, Giulia; Curatolo, Pietro; Banerjee, Shramana; Kis, Erika; Quaglino, Pietro; Pritchard‐ Jones, Rowan; De Terlizzi, Francesca; Grischke, Eva‐ Maria; Kunte, Christian; Department of Dermatosurgery and Dermatology Artemed Clinic of Munich Munich Germany; The Royal London Hospital & QMUL Barts Health NHS Trust Department of Cutaneous Medicine & Surgery London United Kingdom; Department of Dermatologic Surgery St. Josef Hospital Ruhr‐ University Bochum Bochum Germany; Department of Plastic and Reconstructive Surgery Southmead Hospital North Bristol NHS Trust Bristol United Kingdom; Department of Plastic surgery Castle Hill Hospital Cottingham United Kingdom; Plastic Surgery Department The Christie Hospital NHS Foundation trust Manchester United Kingdom; Department of Plastic Surgery Cork University Hospital Cork Ireland; Clinica Chirurgica 1 - Ospedale Policlinico San Martino University of Genova Genova Italy; Center for Experimental Drug and Gene Electrotransfer (C*EDGE) Department of Clinical Oncology and Palliative Care Zealand University Hospital Roskilde Denmark; Plastic Surgery Department James Cook University Hospital Middlesbrough; (Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, v.20, 2022, pp.470-481)
-
338
- Biobanque québécoise de la COVID-19 (BQC19), a COVID-19 biobank to support Canadian health research
- Doroudchi, Mehrnoosh; Rousseau, Simon; Auld, Daniel; Bé rubé , Julie; Bourque, Guillaume; Bujold, David; Chassé , Michaë l; Dé cary, Simon; Falcone, Emilia Liana; Kaufmann, Daniel E.; Messier-Peet, Marc; Montpetit, Alexandre; Mooser, Vincent; Renoux, Christel; Richards, Brent; Tremblay, Karine; Tse, Sze Man; Zawati, Ma’n; Durand, Madeleine; Piché , Alain; The Biobanque Qué bé coise de la COVID-19 (BQC19); The Meakins-Christie Laboratories at the Research Institute of the McGill University Health Centre Research Institute, & Department of Medicine, Faculty of Medicine, McGill University; McGill Genome Centre, McGill University Montré al; The Biobanque Qué bé coise de la COVID-19 (BQC19); McGill Genome Centre, McGill University Montré al; McGill Genome Centre, McGill University Montré al; Le Centre Hospitalier de l’Université de Montré al (CHUM); Faculty of Medicine and Health Sciences, School of Rehabilitation, Research Centre of the CHUS, CIUSSS de l’Estrie-CHUS, Université de Sherbrooke; Institut de Recherches Cliniques de Montré al (IRCM); Le Centre Hospitalier de l’Université de Montré al (CHUM); The Biobanque Qué bé coise de la COVID-19 (BQC19); Centre d’expertise et de Services Gé nome Qué bec; McGill Genome; (Canadian journal of respiratory, critical care, and sleep medicine, v.9, 2025, pp.70-76)
-
339
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management
- Banales, Jesus M.; Marin, Jose J. G.; Lamarca, Angela; Rodrigues, Pedro M.; Khan, Shahid A.; Roberts, Lewis R.; Cardinale, Vincenzo; Carpino, Guido; Andersen, Jesper B.; Braconi, Chiara; Calvisi, Diego F.; Perugorria, Maria J.; Fabris, Luca; Boulter, Luke; Macias, Rocio I. R.; Gaudio, Eugenio; Alvaro, Domenico; Gradilone, Sergio A.; Strazzabosco, Mario; Marzioni, Marco; Coulouarn, Cé dric; Fouassier, Laura; Raggi, Chiara; Invernizzi, Pietro; Mertens, Joachim C.; Moncsek, Anja; Rizvi, Sumera; Heimbach, Julie; Koerkamp, Bas Groot; Bruix, Jordi; Forner, Alejandro; Bridgewater, John; Valle, Juan W.; Gores, Gregory J.; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd, “Instituto de Salud Carlos III”), San Sebastian, Spain; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK; Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain; Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, UK; Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, MN USA; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Rome, Italy; Department of Movement, Human and Health Sciences, Division of Health Scien; (Nature reviews. Gastroenterology & hepatology, v.17, 2020, pp.557-588)
-
340
- Abstract P3-07-28: SERENA-1: Updated analyses from a Phase 1 study of the next generation oral selective estrogen receptor degrader camizestrant (AZD9833) combined with abemaciclib, in women with ER-positive, HER2-negative advanced breast cancer
- Turner, Nicholas; Vaklavas, Christos; Calvo, Emiliano; Garcia-Corbacho, Javier; Incorvati, Jason; Borrego, Manuel Ruiz; Twelves, Chris; Armstrong, Anne; Bermejo, Begoñ a; Hamilton, Erika; Oliveira, Mafalda; Ciruelos, Eva; Kabos, Peter; Patel, Manish R; Borrell, Maria; Burris, Howard; de Paula, Bruno; Falcon, Alejandro; Hernando, Cristina; Moreno, Irene; O’Brien, Ciara S.; Shagisultanova, Elena; Ruiz, Ivan Victoria; Wang, Judy S.; Wei, Mei; Brier, Tim; Carroll, Danielle; Ciardullo, Carmela; Gibbons, Lisa; irurzun-Arana, itziar; Jack, Tony; kirova, bistra; Klinowska, Teresa; Lindemann, Justin; Maidment, Julie; Mathewson, Alastair; Maudsley, Rhiannon; McEwen, Robert; Morrow, Christopher; Sykes, Andy; Baird, Richard D.; 1The Royal Marsden Hospital, London, United Kingdom; 2Huntsman Cancer Institute; 3START Madrid-CIOCC; 4Hospital Clinic Barcelona/IDIBAPs; 5Fox Chase Cancer Center; 6Hospital Universitario Virgen del Rocio, Sevilla, Andalucia, Spain; 7University of Leeds/Leeds Teaching Hospitals Trust, Leeds, United Kingdom; 8The Christie NHS Foundation Trust; 9Hospital Clí nico Universitario de Valencia, Valencia, Spain; 10Sarah Cannon Research Institute, Nashville, TN; 11Department of Medical Oncology, Vall d’Hebron University Hospital; Breast Cancer Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain; 12SOLTI Breast Cancer Research Group, Barcelona, Spain/Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain, Madrid, Spain; 13University of Colorado Denver, Aurora, CO, Aurora, Colorado; 14Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL, Sarasota, Florida; 15Vall d’Hebron University Hospital, and Breast Cancer Group, Val; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.P3-07-28-P3-07-28)
QUICK MENU
